Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FRA:Q8T'
s EV-to-FCF Range Over the Past 10 Years
Min: 5.63 Med: 49.79 Max: 218.52
Current: 19.72
During the past 7 years, the highest EV-to-FCF of OrbusNeich Medical Group Holdings was 218.52. The lowest was 5.63. And the median was 49.79.
FRA:Q8T's EV-to-FCF is ranked better than 87.8% of 418
companies
in the Medical Devices & Instruments industry
Industry Median: 23.065
vs FRA:Q8T: 19.72
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
OrbusNeich Medical Group Holdings (FRA:Q8T) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
OrbusNeich Medical Group Holdings's PE Ratio (TTM) for today is calculated as:
OrbusNeich Medical Group Holdings's share price for today is €0.348.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. OrbusNeich Medical Group Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was €0.045.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
OrbusNeich Medical Group Holdings EV-to-FCF Related Terms
OrbusNeich Medical Group Holdings EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OrbusNeich Medical Group Holdings EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where OrbusNeich Medical Group Holdings's EV-to-FCF falls into.
OrbusNeich Medical Group Holdings's current Enterprise Value is €180.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. OrbusNeich Medical Group Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was €8.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OrbusNeich Medical Group Holdings (FRA:Q8T) has a EV-to-FCF of 21.04 as of Sep. 17, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on OrbusNeich Medical Group Holdings and its competitors. This is 58% below median its historical median of 49.79. Over the past decade, OrbusNeich Medical Group Holdings' EV-to-FCF has ranged from 5.63 to 218.52. According to the industry distribution chart, OrbusNeich Medical Group Holdings ranks #51 out of 418 companies in the Medical Devices & Instruments industry, placing it in the top 12.2%.
Is OrbusNeich Medical Group Holdings' EV-to-FCF too high?
OrbusNeich Medical Group Holdings' current EV-to-FCF of 21.04 is 58% below median its 10-year median of 49.79. Over the past 10 years, this metric has ranged from a low of 5.63 to a high of 218.52. The Medical Devices & Instruments industry median EV-to-FCF is 23.07. OrbusNeich Medical Group Holdings' value of 21.04 is 8.8% below this industry median. Based on the distribution chart, OrbusNeich Medical Group Holdings ranks #51 out of 418 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, OrbusNeich Medical Group Holdings has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does OrbusNeich Medical Group Holdings' EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, OrbusNeich Medical Group Holdings ranks #51 out of 418 companies for EV-to-FCF. This places OrbusNeich Medical Group Holdings in the top 12% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 23.07. OrbusNeich Medical Group Holdings' value of 21.04 is 8.8% below this benchmark. Historically, OrbusNeich Medical Group Holdings' own EV-to-FCF has ranged from 5.63 to 218.52 over the past decade. While the company's 10-year median is 49.79 vs. the industry median of 23.07, OrbusNeich Medical Group Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.07, based on 418 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OrbusNeich Medical Group Holdings's current EV-to-FCF of 21.04 is 8.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on OrbusNeich Medical Group Holdings and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OrbusNeich Medical Group Holdings's current EV-to-FCF is 21.04, which is 58% below median its own 10-year median of 49.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrbusNeich Medical Group Holdings stock overvalued right now?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a current EV-to-FCF of 21.04. The stock's GF Value™ is €0.46, compared to a current price of €0.35 — trading 24.3% below its estimated fair value. The current EV-to-FCF is 21.04, which is 58% below median its 10-year median of 49.79 and 8.8% below the Medical Devices & Instruments industry median of 23.07. OrbusNeich Medical Group Holdings' overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For OrbusNeich Medical Group Holdings (FRA:Q8T), the current EV-to-FCF is 21.04 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OrbusNeich Medical Group Holdings (FRA:Q8T) Overvalued in 2026?
Based on GuruFocus' analysis, OrbusNeich Medical Group Holdings stock appears to be undervalued.
The current stock price of €0.35 is trading 24.3% below its estimated GF Value™ of €0.46.
Key valuation signals for FRA:Q8T:
EV-to-FCF: 21.04 (58% below median its 10-year median of 49.79)
GF Value™: €0.46 vs. price of €0.35 (24.3% below fair value)
Industry Position: 8.8% below the Medical Devices & Instruments median (#51 of 418)
No single metric tells the full story. See the FRA:Q8T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OrbusNeich Medical Group Holdings Ltd is an investment holding company. The Company principally engaged in the manufacturing, trading, sales and marketing of medical devices/instruments used for the treatment of coronary and peripheral vascular diseases. The group has only one operating segment. The company has presence in APAC, EMEA, Japan, United States, The PRC, and Others of which majority of revenue comes from APAC.
95GF Score
Get the complete analysis for FRA:Q8T
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:Q8T has been successfully added to your 
